Role of 5-alpha-reductase inhibitors in active surveillance of patients with low-risk prostate cancer.
Andrew Szehsun Chiang
No relevant relationships to disclose
D. Andrew Loblaw
No relevant relationships to disclose
Vibhuti Jethava
No relevant relationships to disclose
Perakaa Sethukavalan
No relevant relationships to disclose
Liying Zhang
No relevant relationships to disclose
Danny Vesprini
No relevant relationships to disclose
Alexandre Mamedov
No relevant relationships to disclose
Robert Nam
No relevant relationships to disclose
Laurence Klotz
No relevant relationships to disclose